Company intelligence / Profile preview

Aizon

San Francisco, California, United Statesaizon.ai ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Aizon provides an AI-powered, GxP-compliant software platform and consulting services to optimize manufacturing operations for pharmaceutical and biotech companies. Their solutions focus on predictive analytics, real-time monitoring, digital twins, electronic batch records, and regulatory compliance to improve yield, quality, and efficiency in drug substance/product manufacturing[1][4][5].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

SequenceEuroapi

Beyond the preview

Go deeper on Aizon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aizon.

Explore the full profile